R & D
Spread over 2,300 Sq. ft. areas. S.M.Pharmaceuticals R & D facilities, recognized by the Department of Science & Technology, Government of India, are manned by a 10 strong scientists’ pool. A centralized Quality Control & Analytical Research Laboratory has been set up to meet the domestic and international quality standards.
The Company has expanded operations by building further on already existing set-up by investing in new premises, to include modern, state-of-the-art amenities.
A strong new product pipeline, one that is continually replenished, is vital for our success as a all therapeutic segments. Which is why we’ve continually invested in a strong team, regulatory standards labs and equipment? Our R&D projects enable us to bring new products to India, build a strong pipeline
We look at partnering and collaborating as an important strategic approach that will complement our growth in India and international markets. Our constant need is to add to our specialty product portfolio for prescription leadership in India. We also seek to strengthen our presence, with a complete basket of specialty products in world wide.
We are currently interested in in-licensing products that are already marketed or are in late stage clinical development in our key therapy areas. We seek products that leverage our core strengths and complement our existing product portfolio in the following therapy areas:
- CNS disorders
- Diabetes and Metabolic disorders
- Allergy, Asthma and Inflammation